Read + Share
Amedeo Smart
Independent Medical Education
Khosravi-Hafshejani T, Werth VP. Serum IFNalpha as a Biomarker for Cutaneous Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application. J Invest Dermatol 2025 Jan 30:S0022-202X(25)00020.PMID: 39891646
Email
LinkedIn
Privacy Policy